BlackRock Amends Biogen Stake, Signals Ownership Change
Ticker: BIIB · Form: SC 13G/A · Filed: Jan 24, 2024 · CIK: 875045
| Field | Detail |
|---|---|
| Company | Biogen Inc. (BIIB) |
| Form Type | SC 13G/A |
| Filed Date | Jan 24, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, biotech
TL;DR
**BlackRock updated its Biogen stake, watch for potential market reaction.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 24, 2024, disclosing its ownership of Biogen Inc. common stock as of December 31, 2023. This amendment, number 14, indicates a change in BlackRock's beneficial ownership, which is important for investors as BlackRock is a major institutional investor and its movements can signal shifts in market sentiment or investment strategy regarding Biogen. This matters to current or prospective Biogen shareholders because large institutional holdings can influence stock stability and future price movements.
Why It Matters
This filing shows BlackRock's updated position in Biogen, which can influence other investors' perceptions and potentially impact Biogen's stock price due to the sheer size of BlackRock's investments.
Risk Assessment
Risk Level: low — This is a routine update from a large institutional investor and does not inherently signal high risk, though changes in ownership can have minor market impacts.
Analyst Insight
Investors should monitor future BlackRock filings for Biogen to track any significant changes in their ownership percentage, as large shifts could indicate a change in their investment thesis for the company.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- BIOGEN INC. (company) — the subject company whose shares are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 24, 2024 (date) — the filing date of the SC 13G/A
- Amendment No: 14 (number) — the specific amendment number for this filing
Forward-Looking Statements
- BlackRock will continue to be a significant institutional holder of Biogen stock. (BlackRock Inc.) — high confidence, target: 2025-12-31
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, filed under Rule 13d-1(b) of the Securities Exchange Act of 1934.
Who is the 'subject company' in this filing?
The subject company is BIOGEN INC., identified by CIK 0000875045 and CUSIP Number 09062X103.
Who is the 'filed by' entity in this document?
The entity that filed this document is BlackRock Inc., identified by CIK 0001364742.
What was the 'Date of Event Which Requires Filing of this Statement'?
The date of the event which requires the filing of this statement was December 31, 2023.
What is the 'Amendment No.' for this specific filing?
This specific filing is Amendment No: 14 to the Schedule 13G for BIOGEN INC.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 24, 2024 regarding BIOGEN INC. (BIIB).